Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be individualized based on the patient's current treatment, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This medicine is generally taken once daily with the evening meal.
The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy:
When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Adjust the dose gradually to reduce gastrointestinal adverse reactions associated with metformin.
For patients switching to this medicine from combination therapy with dapagliflozin and metformin, this medicine may be started at the previous doses of dapagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Since any change may cause alterations in glycemic control, changes in the treatment of patients with type 2 diabetes should be made under careful monitoring.
Swallow this medicine whole. Do not crush, cut, or chew it. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet.
Renal impairment
No dose adjustment is necessary for patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who have no other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg.
Use of this medicine is not recommended in patients with an eGFR less than 45 mL/min/1.73m2.
Discontinue this medicine immediately if the eGFR falls below 45 mL/min/1.73m2. Renal function should be assessed every 3~6 months.
Elderly patients
Metformin is excreted by the kidneys, and elderly patients are more likely to have decreased renal function; therefore, this medicine should be used with caution as age increases (see Precautions for Use, 9. Use in Elderly Patients).
Improvement of glycemic control in adults with type 2 diabetes mellitus
View approved original textHide original text
This medication is used as an adjunct to dietary and exercise therapy to help control blood glucose levels in adult patients with type 2 diabetes who are appropriate candidates for combined treatment with dapagliflozin and metformin. It should be administered particularly when blood glucose is not adequately controlled and should be used with caution in patients with cardiovascular diseases or risk factors. This medication effectively improves blood glucose control and aids overall diabetes management.
How to take
Adult dose
The dose of this medicine should be individualized based on the patient's current treatment, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg.
This medicine is generally taken once daily with the evening meal.
The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg.
Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy:
When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Adjust the dose gradually to reduce gastrointestinal adverse reactions associated with metformin.
For patients switching to this medicine from combination therapy with dapagliflozin and metformin, this medicine may be started at the previous doses of dapagliflozin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted appropriately.
The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other glucose-lowering medicines. Since any change may cause alterations in glycemic control, changes in the treatment of patients with type 2 diabetes should be made under careful monitoring.
Swallow this medicine whole. Do not crush, cut, or chew it. Occasionally, inactive ingredients in this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet.
Renal impairment
No dose adjustment is necessary for patients with mild renal impairment.
For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2 who have no other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg.
Use of this medicine is not recommended in patients with an eGFR less than 45 mL/min/1.73m2.
Discontinue this medicine immediately if the eGFR falls below 45 mL/min/1.73m2. Renal function should be assessed every 3~6 months.
Elderly patients
Metformin is excreted by the kidneys, and elderly patients are more likely to have decreased renal function; therefore, this medicine should be used with caution as age increases (see Precautions for Use, 9. Use in Elderly Patients).
Precautions
This medication helps to control blood glucose levels.
However, it can rarely cause a serious condition called lactic acidosis, which requires caution.
Be careful, as hypoglycemia can occur when taken with other diabetes medications.
It should not be used in patients with significantly impaired kidney function or in conditions such as severe infection, dehydration, or acute myocardial infarction.
Pregnant and breastfeeding women should also not take this medication.
Elderly patients or those with weakened kidney function should ensure that kidney function is monitored prior to and during use of this medication.
This medication can increase the risk of genital infections and urinary tract infections, so treatment should be sought promptly if symptoms appear.
Dehydration or hypotension symptoms due to reduced fluid volume may also occur, requiring caution.
Vitamin B12 deficiency may occur, so regular blood tests are recommended if taken for an extended period.
Excessive alcohol consumption can increase risks, and it is advisable to avoid drinking alcohol.
Before surgery or radiographic examinations with contrast agents, the medication should be discontinued for a period and resumed only after confirming normal kidney function.
During treatment with this medication, be vigilant for hypoglycemic symptoms, and dosage adjustments may be necessary if taken with insulin or other hypoglycemic agents.
In case of overdose, seek medical attention immediately for proper treatment.
This medication is not used in children or pregnant women as its safety has not been established.
This medication does not significantly affect the ability to drive or operate machinery, but dizziness may occur, so caution is advised.
Store the medication out of reach of children and in its original container to maintain quality.
Side effects
Severe lactic acidosis
severe hypoglycemia
vulvovaginitis
balanitis
related genital infections
urinary tract infections
fungal infections
hypoglycemia
fluid volume depletion
thirst
Show 84 moreCollapse
diabetic ketoacidosis
dizziness
constipation
dry mouth
back pain
dysuria
polyuria
nocturia
vulvar pruritus
genital pruritus
elevated hematocrit
decreased renal creatinine clearance
dyslipidemia
elevated serum creatinine
elevated serum urea
weight loss
ketoacidosis
urosepsis
pyelonephritis
acute kidney injury
renal dysfunction
rash
diarrhea
nausea
vomiting
decreased vitamin B12
Guillain-Barré syndrome
bacterial pneumonia
sialadenitis
tendinitis
chest pain
thermal burn
wrist fracture
gastrointestinal stromal tumor
malignant lung neoplasm
uterine fibroids
atrial fibrillation
acute cholecystitis
epigastric pain
dyspepsia
abdominal discomfort
abdominal pain
gastric ulcer
irritable bowel syndrome
salivary gland mass
toothache
headache
facial paralysis
peripheral neuropathy
sensory abnormalities
drowsiness
tremor
nasopharyngitis
pharyngitis
adenoviral conjunctivitis
herpes zoster
pneumonia
rhinitis
elevated alanine aminotransferase
increased blood sugar
arthralgia
myalgia
myofascial pain syndrome
osteoarthritis
osteochondrosis
limb pain
periarticular inflammation
tendinitis
trigger finger
myasthenia
fatigue
peripheral edema
edema
pain
vitamin D deficiency
hyperglycemia
urethral syndrome
cough
hyperventilation
pruritus
palpitations
insomnia
type 2a hyperlipidemia
sensorineural hearing loss
Not everyone experiences these, and they can vary from person to person.
Storage
This medication is sensitive to air and moisture, so it must be stored in a well-sealed container. It is important to maintain the storage temperature between 1 degree and 30 degrees Celsius.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.